Although we did not find a correlation between age and anti-ENO1 antibody levels in our adult cohorts, the control group was significantly younger than the AML and MDS groups, and this may have influenced the finding of decreased anti-ENO1 antibody levels in these patient groups (Figure 3). The gene discussed is ENO1; the disease is acute myeloid leukemia.